The general public will subscribe 6.25 million shares, 25 percent of the total offer size of BF Biosciences IPO on October 2nd and 3rd at the strike price of Rs 77.
The general public can subscribe the IPO on 2nd and 3rd October from 9.00 am to 5pm during banking hours. However, in the case of e-IPO, the process continues for 24 hours.
BF Biosciences IPO Receives Overwhelming Response from Investors
The book-building phase of BF Biosciences concluded last week with an oversubscription of 3.4 times.
The IPO received an overwhelming response from institutional investors and high-net worth individuals as the strike price clocked in at Rs 77/share, 40 percent higher than the floor price of Rs 55 and raised Rs 1.93 billion.
Shahid Ali, CEO Arif Habib Limited said that investing in the public offering of BF Biosciences presents a decent opportunity for retail investors to engage with a fundamentally strong company at a more attractive valuation compared to the broader pharmaceutical sector.
This unique positioning allows investors to capitalize on potential growth while benefiting from a favorable entry point.
Master Auto Engineering (MAE), the official partner of Chery vehicles in Pakistan, celebrates another major…
BingX, a leading cryptocurrency exchange and Web3-AI company, today announced the appointment of Kevin Lee…
JazzWorld reported revenue of more than PKR 269 billion in the first half of 2026,…
Novo Nordisk, the global healthcare company with more than a century of leadership in diabetes…
Nine Pakistani nationals have been deported from Poland after a failed attempt to enter the…
K-Electric (KE) has earned international recognition by winning the Gold Stevie® Award at the 11th…
This website uses cookies.
